Nick Sundich
Straker (ASX:STG): After a difficult few years, could AI be a major growth catalyst?
Is Straker (ASX:STG) just one of those companies using the term ‘AI’ just to attract attention when nothing else is…
Here are The Most Common Behavioural Finance Biases Investors can Succumb To And How to Avoid Them
If you’ve ever looked back on an investment decision and not been able to comprehend how you could’ve made it,…
News Corp (ASX:NWS): Now that Rupert’s baton will pass only to Lachlan, what will its future hold?
News Corp is one of Australia’s most controversial companies. Many may not know it is still technically listed in Australia…
Here are 7 regulators that ASX investors need to be aware of
There are several regulators that ASX investors need to be aware of. because they directly affect the safety, transparency, and…
Avita Medical (ASX:AVH): It hasn’t catapulted it to the heights envisioned (yet), but there’s hope for the 2026 and 2027
Avita Medical (ASX:AVH/NDQ:RCEL) is a particularly peculiar healthcare stock. The company, these days based in the Californian city of Valencia…
Which ASX Big Four Bank Stock to Buy?
Let’s take a look at a question many investors would ponder: Which ASX Big Four Bank Stock to Buy? If…
Fast food stocks: They are meant to be recession proof, so why have they left investors disappointed ever since the pandemic?
Fast food stocks are meant to be recession-proof, at least in theory. When consumers tighten their belts, they look for…
Animoca Brands: The Web3 company that got away from the ASX, and our loss is the Nasdaq’s gain
Who would’ve thought that more than 5 years after Animoca Brands was unceremoniously dumped from the ASX, it is listing…
3 years since Block shares listed on the ASX: It was set to soar new heights in 2025, until Trump’s tariffs
The Afterpay acquisition was not just noteworthy because it was the biggest corporate takeover in Australian history, but also because…
Do KMD Brands (Kathmandu) investors finally have light at the end of the tunnel after a difficult 4 years?
Investors in KMD Brands who bought right as the pandemic lockdowns ended would have seen their investment retreat over 80%…
Air New Zealand (ASX:AIZ): Why hasn’t it bounced back from the pandemic like Qantas?
Air New Zealand (ASX:AIZ) and Qantas (ASX:QAN) both suffered the indignity of having their market demand wiped out due to…
So, your ASX stock is a Foreign Exempt Entity? Here’s what you need to know?
Some ASX stocks are designated as a Foreign Exempt Entity. Not all overseas domiciled stocks have this status, but all…
Pexa (ASX:PXA): Trying to expand into the Old Dart
Pеxa (ASX:PXA) is one of the few stocks with a literal monopoly over its market e-Conveyancing; but even fewer companies…
Broadcom (NDQ:AVGO): Meet the US$1.75tn chip maker that’s displaced Tesla from the Magnificent Seven
Broadcom (NDQ:AVGO) is probably the most under appreciated of the (currently) 12 stocks that are capped at over US$1tn. And…
Here are 9 of the most famous speculative bubbles in history and what investors can learn from them
Speculative bubbles are a common occurrence in financial markets. Investors are wondering if the AI boom is another one of…
DorsaVi (ASX:DVL): This sensor business is now the newest ReRAM player
The game has changed for DorsaVi (ASX:DVL) and its investors. For many years, it has had a sensor business focused…
Should I buy Woolworths or Coles shares in FY26? And why is Coles performing better right now?
Should I buy Woolworths or Coles shares? This is one of the top debates Australian investors can have. Obviously, this…
Should you buy Nvidia shares in Australia? Here’s everything you need to know about the US$5tn behemoth that is the world’s largest company!
Many investors are likely wondering if they should buy Nvidia shares in Australia? As it crossed each trillion dollar mark,…
Spotify Technology (NYSE:SPOT): A pioneer of the freemium model and an expert at getting users to pay up
Music was a product, now it is a service and Spotify Technology (NYSE:SPOT) has the largest market share with just…
Wesfarmers (ASX:WES): It thrived when inflation was at 40-year highs; but is worried about the threats of crime and new taxes?
As retailers announced downgrades left right and centre during the cost of living crisis, Wesfarmers (ASX:WES) was an exception. Its…
After a 80% plunge in 10 months, Mineral Resources (ASX:MIN) is back with a vengeance and has nearly tripled!
Mineral Resources (ASX:MIN) has had quite the rollercoaster ride in recent years. It avoided much of the lithium price rout,…
JB Hi Fi (ASX:JBH): With a 140% gain in 2 years, it is the ASX’s most in vogue retailer!
Few retailers have emerged stronger from the pandemic than when it began, but it is hard to argue JB Hi…
How to avoid getting caught in investor hype? Here are 5 ways to differentiate FOMO from long-term growth
Getting caught in investor hype is not the only trap investors can get caught into, but it is one of…
Here are 8 of the most important takeovers on the ASX so far in 2025!
This article recaps 8 of the most important takeovers on the ASX in 2025! This list is not necessarily the…
Sherwin Williams (NYSE:SHW): Who said nothing good comes out of Cleveland? All it gave us was a US$83bn paint giant
Sherwin Williams (NYSE:SHW) is a near 160-year-old paint company from Cleveland, Ohio capped at over US$85bn. This company is one…
Will Regional Express investors get any of their money back or will they be wiped out?
Regional Express investors have waited more than 12 months to get an answer as to what will happen next…but they…
Corporate Travel Management (ASX:CTD): Its management has lot of work to do, just to resume trading
No matter how impressive an underlying thematic of an individual may be, Corporate Travel Management (ASX:CTD) depicts to investors that…
Weebit Nano (ASX:WBT): Here’s why it has done so well and why the next 2 years will be extremely exciting!
Our long-time followers would know we are big fans of Weebit Nano (ASX:WBT). This company has delivered stellar returns to…
Colgate (NYSE:CL): There’s more to it than toothpaste – it could be the best way to profit from the growth in pet products!
In Australia, we know Colgate (NYSE:CL) primarily as a toothpaste brand. But there’s a lot more to this 217-year old…
Here are 5 ASX resources stocks with New Zealand projects
In this article, we’re taking a look at ASX resources stocks with New Zealand projects. It is easy for investors…
Beforepay (ASX:B4P): It survived the post-COVID BNPL Bust, and appears to be thriving…but is it really?
After a disasterous IPO, Beforepay (ASX:B4P) appears to be thriving. After all, its share price is up over 500% in…
Core Lithium (ASX:CXO): The share price has bottomed out, but will FY26 be the year it restarts Finniss
Core Lithium (ASX: CXO) was one of the hottest ASX stocks post-pandemic, not just lithium stocks but all stocks. The…
Telstra shares are at a 10-year high and the company is at an exciting point in its history
Last time we wrote about Telstra shares, it was in mid-FY24 and the company was under pressure. But 15 months…
Beyond Meat (NDQ:BYND) became the latest Reddit meme stock…for a few days before crashing back to earth
It is rarer to see a Reddit meme stock in 2025 than it was in 2021, but we just saw…
Should you invest in ASX Gold ETFs? And what are the best ones to consider?
Should you invest in ASX Gold ETFs? In case you’ve been living under a rock, gold is up over 50%…
When will Canva list? Perhaps in the next 12-18 months, but here’s why it will give the ASX the cold shoulder
When will Canva list? This has been a hot question for several years now. Sometimes it has seen like it…
Commodity prices: Here are 4 factors that determine whether they rise or fall
Commodity prices are amongst the most volatile asset prices in the financial markets – even more than stocks and bonds.…
Vertex Pharmaceuticals (NDQ:VRTX): Another >US$100bn biotech that is facing the cliff like its peers, but might be safer
$100bn biotechs like Vertex Pharmaceuticals (NDQ:VRTX) typically get to their position through ‘blockbuster drugs’ with periods of market exclusivity, which…
South32 (ASX:S32): Is it the dark horse amongst ASX 200 miners or have cyclones and commodity prices hit it too hard?
South32 (ASX:S32) began life as a spinoff from BHP back in 2015, capitalised at $9bn. In mid-October 2025, it is…
Walmart (NYSE:WMT) shares may be a safe investment, but are they a growth investment?
This week’s international stock deep dive in on Walmart (NYSE:WMT). While most of our Australian readers may not have shopped…
There’s a US$180bn Biotech Patent Cliff coming! Here’s why it could spell doom for large caps, but a generational opportunity for small caps
There’s a Biotech Patent Cliff coming over the next decade! Investors aren’t giving this much attention, but we think they…
Here are 5 ASX Stocks Hancock Prospecting is invested in; and why Gina Rinehart’s company is into rare earths
The list of ASX Stocks Hancock Prospecting is invested in became one member longer the other day, as Gina Rinehart’s…
Airbnb shares have flatlined since the 2020 IPO, but now could finally be their time to shine
Airbnb (NDQ:ABNB) has been a fascinating company to watch since listing in December 2020. On one hand it has not…
Could gold prices crash in 2026? Here are 5 reasons why gold might crash spectacularly and 5 reasons why it might continue to rally
The possibility that gold prices crash in 2026 (or even in 2025) is a prospect that no investor should rule…
A2 Milk (ASX:A2M) is successfully adjusting to a ‘new normal’ in the China infant formula market
A2 Milk shares have been listed on the ASX for over 10 years, listing in late March 2015 at $2.30…
ERoad (ASX:ERD): Set to benefit from a major tax reform forthcoming in New Zealand but just committed a cardinal sin
You may loathe the regulations on our roads and some companies that profit from them like Transurban, but ERoad (ASX:ERD)…
Relative Strength Index (RSI): Here’s how investors can use it to their advantage; and 5 stocks at either extreme
One of the simplest technical indicators that investors can employ is the Relative Strength Index (RSI). How does it work…
Baby Bunting (ASX:BBN): FY25 was a better and investors finally gave it recognition, but did they get ahead of themselves?
After being the poster child for what’s happening retailers in a cost of living crisis, Baby Bunting (ASX:BBN) appears to…
This ASX semiconductor play is about to solve a major bottleneck
ASX semiconductor play Adisyn (ASX:AI1) is at a pivotal point in its development journey. By this time next year, the…
Bellevue Gold (ASX:BGL): One of Australia’s newest gold producers fell >50% from its peak, but is now recovering
Bellevue Gold (ASX:BGL) is one of Australia’s newest gold producers, but one of the few gold stocks to be down…
CET1 ratio: If you invest in ASX bank stocks, here’s why it is an important metric to know
In this article we look at the Common Equity Tier 1 (CET1) ratio – what it is and why it…
6 ASX companies experiencing a better FY26 following a poor FY25
There are already some ASX companies experiencing a better FY26 than FY25. It may only be 3 and a half…
St George has raised a staggering $72.5m to advance Araxa & Gina Rinehart’s Hancock Prospecting chipped in $22.5m!
Gina Rinehart’s Hancock Prospecting has invested $22.5m in St George Mining’s (ASX:SGQ) latest capital raising. It caps off a spectacular…
Can Ryman Healthcare (ASX:RYM) succeed where its peers have failed?
Ryman Healthcare (ASX:RYM) is New Zealand’s largest aged care operator and is one of the ASX’s newest companies. It has…
Rejecting a takeover offer: Here are 6 ASX stocks that did and how it ended for them
Rejecting a takeover offer is a bold step for an ASX company to take. It is turning down sweet quick…
Pfizer (NYSE:PFE) shares are still declining post-pandemic! Does the company have a future?
The dream run Pfizer had during the pandemic was not going to last forever. But while certain companies that derived…
The RBNZ is cutting rates again, and here are 5 ASX stocks (based in New Zealand) that could benefit
Last week, we heard that the RBNZ is cutting rates again. If you thought Australia’s economy was not doing well,…
When Ray Dalio Talks, Investors Listen! Here’s His Latest Advice For Investors!
As one of the world’s most famous and successful investors, Ray Dalio’s words are always taken notice of by the…
Lithium in 2025: Have the hopes of a recovery been another false dawn? It looks that way
The market for Lithium in 2025 has been a case of same old, same old. There has arguably been the…
Currency hedging: Here’s how it works and why it’s so important to so many companies and investors
You’ll commonly hear the term ‘currency hedging’. It is undertaken by many companies as part of the ordinary course of…
Mesoblast (ASX:MSB): Which direction will this rollercoaster of a $3bn biotech company go next?
Biotech company Mesoblast (ASX:MSB) is the ultimate definition of a rollercoaster company. As of October 7, 2025, it is capped…
PainChek (ASX:PCK): Investors dreamed 2025 would be the year it finally enters the US market, and their dreams are becoming a reality!
PainChek (ASX:PCK) has among the most admirable medical technologies there is, in the form of an app that can detect…
Cyclopharm (ASX:CYC): FDA approved for 2 years now, but a lawsuit from 4DX is the latest headache and cause for investor scepticism
Cyclopharm (ASX:CYC) is a rare species – an ASX stock that is approved in the US market. However, its share…
Activist investors: Here’s what you need to know about them and 4 famous Australian activists to watch out for
Hear the term ‘Activist investors’ and you might think of GetUp, the progressive activist group that forced Woolworths to hold…
Peninsula Energy (ASX:PEN): It was arguably the ASX best uranium play, but 2025 was an annus horribilus
This week we are taking an in-depth look at Peninsula Energy (ASX:PEN). It is one of a handful of uranium…
Predictive Discovery (ASX:PDI) and Robex (ASK:RXR) are merging to become a major gold miner; but is West Africa too risky?
On Monday October 6 2025, whilst NSW and Queensland were on holiday, Predictive Discovery (ASX:PDI) and Robex (ASK:RXR) investors were…
Nuix (ASX:NXL) has fallen 50% in 12 months! But shares may have taken a turn for the better in recent weeks
After closing 2024 with a share price that had more than tripled in 12 months, Nuix (ASX:NXL) has halved so…
Lynas Rare Earths (ASX:LYC): The best of the bunch in a sector bound for better times
Lynas Rare Earths (ASX:LYC) is in our view the best company in the rare earths sector. You may not realise…
Pepper Money (ASX:PPM): Flexibility is better…if you’re a borrower but what if you’re an investor?
Pepper Money’s (ASX:PPM) promise to borrowers has been flexibility. You may not be ‘good enough’ to match the Big Banks’…
Am I sophisticated investor? Here’s how to tell and what special privileges it gives you
Am I sophisticated investor? That is a question commonly asked, and one that you could answer yes to simply on…
Why Do Investors Hate the Southern Cross Seven West Media Merger? Here are 6 reasons why
Ever since the Southern Cross Seven West Media Merger was announced back on Tuesday (September 30), it has been met…
Here’s what you need to know about AML and CTF laws if you invest in The Big 4 Banks
AML and CTF laws are particularly relevant to a handful of large companies, particularly the Big Four Banks as well…
Mirvac (ASX:MGR): Things are set to get worse before they get better
Founded in 1972, Mirvac (ASX:MGR) is Australia’s largest listed developer of residential, commercial and industrial property. Arguably, it is one…
Intelligent Monitoring Group (ASX:IMB): This >$200m All Ords company is Australasia’s largest independent security monitoring provider!
After a terrific FY24, FY25 was more difficult for Intelligent Monitoring Group (ASX:IMB) but it may have turned a corner.…
Are we in a Goldilocks economy right now? What does this term even mean and how will it impact the market?
In the past few months, the term Goldilocks economy has been thrown about with suggestions we have (or perhaps just…
EBR Systems (ASX:EBR): Another heart-focused medtech that has gained FDA approval
Mere days after Artrya (ASX:AYA) obtained FDA approval for its heart-health technology, EBR Systems (ASX:EBR) has achieved that same feat.…
Judo Bank (ASX:JDO): Gradually getting the recognition it deserves?
Judo Bank (ASX:JDO) had a difficult 4 years since listing in late 2021 and has traded mostly below the IPO…
Which stocks that benefit from inflation the most? Here are 3 sectors to watch
Stocks that benefit from inflation do exist, but they might not be immediately obvious to find. After all, inflation can be…
Here’s how inflation is calculated in Australia…and makes the RBA decide which way interest rates move
How inflation is calculated is a controversial topic. It is nothing but a rough attempt to measure the level of…
Treasury Wine Estates (ASX:TWE): China’s 200% wine tariffs have been consigned to history, so is it now back to business as usual?
Poor Treasury Wine Estates (ASX:TWE) investors! After 3 and a half years of China’s 200% tariffs on Australian wine imports,…
Proteomics has launched 2 Promarker tests in a matter on months and is about to launch a 3rd
Proteomics‘ suite of Promarker tests are all being launched in 2025. The range includes: PromarkerD for DKD which has been…
The S&P/ASX All Technology Index: Here’s what investors need to know, and the 5 top stocks in it!
In the last 12 months, the S&P/ASX All Technology Index celebrated 6 years since inception and has netted a return…
Maas Group (ASX:MGH): Why investors should keep a keen eye on it in FY26!
It is a tough time to be a construction company, but Maas Group (ASX:MGH) hasn’t fared that bad all things…
What will the Qantas A321XLRs mean for the group? Hint: Investors should be excited but also cautious!
The first of Qantas A321XLRs is now taking passenger flights – the first flight occurred today (September 25) and it…
Here are 5 ASX stocks with obscure HQ locations
Here are 5 ASX stocks with obscure HQ locations! What are the Best ASX Stocks to invest in right now?…
Myer (ASX:MYR): Investors hated its FY25 results with a passion, but the company is optimistic better times are ahead
Myer (ASX:MYR) made headlines earlier this week after its FY25 results – shares fell >25%. Were results that bad? Maybe…
Atlas Arteria (ASX:ALX): Meet the ASX’s other toll road operator – a company with no exposure to Australia
Atlas Arteria (ASX:ALX) is one of two toll road operators on the ASX, with the other being Transurban (ASX:TCL). But…
Bulls and Bears: Who are these investors and how do they invest their money?
You’ve likely heard of the term or terms ‘Bulls and Bears’ describing two different types of investor sentiment, and of…
St George Mining has surged from $50m to >$250m in just 5 months and its latest drilling results are spectacular!
St George Mining (ASX:SGQ) has had a spectacular few months capped off with its latest drilling results. Its Araxa Niobium-REE…
Amplia Therapeutics (ASX:ATX): Battling pancreatic cancer with an FAK inhibitor
Amplia Therapeutics (ASX:ATX) is another ASX oncology biotech company, attempting to battle cancer. At first glance, it may not a…
Is another boom in ASX BNPL stocks brewing? And how would Mk. 2 differ from Mk. 1
Is a new era on the horizon for ASX BNPL stocks? After a boom that lasted from Afterpay’s May 2016…
6 Trends on ASX Company Boards That Should Raise Investor Eyebrows
Last week, Ownership Matters released a major report on ASX Company Boards. The report, studied ASX 300 entities (excluding ‘stapled…
Intel (NDQ:INTC): Its been outmuscled by Nvidia, but its rival just became an investor by buying a US$5bn stake
Intel (NDQ:INTC) has a peculiar shareholder register that has included the US government (which bought 10% in August), Japan’s SoftBank…
Atlassian (NDQ:TEAM): Will this Aussie home grown tech company be made or broken by the AI boom?
Are Aussie investors really poorer for not having Atlassian (NDQ:TEAM) on the ASX? While many of the ASX’s tech stocks…
Here are 5 AI tools to use in investing and how they can help
In this article, we take a look at 5 AI tools to use in investing. A few months ago, we…
Nexsen: Another ‘point of care diagnostics’ company is about to hit the ASX
There’s another company about to join the cohort of ASX biotech stocks and its name is Nexsen. Nexsen is proposed…